Higher lipoprotein(a) concentration is associated with a blunted response to iron repletion in women with low iron stores: a secondary analysis of a randomized controlled trial.
Abstract
Background
Lipoprotein(a) [Lp(a)] is a pro-inflammatory lipoprotein, and higher concentrations are associated with increased risk of deficiency anemias.
Objective
To examine relationships between Lp(a) concentration and indicators of iron status, anemia, and inflammation before and after an 8-week iron supplementation intervention in women of reproductive age with low iron stores (ferritin <25 μg/L).
Methods
A secondary analysis of a randomized two-arm parallel trial was conducted. Fifty-two participants (age = 25 ±7 y; body mass index = 23 ±3 kg/m2) were given an iron supplement (32 mg elemental iron as iron sulfate) with a lunch meal containing beef or a plant-based meat alternative daily for 8 weeks. Indicators of iron status, anemia, and inflammation, and Lp(a) concentrations were measured at baseline and post-intervention. Linear regression was used to test associations between baseline Lp(a) concentrations (independent variable) and indicators of iron status, anemia, and inflammation (dependent variables) before and after the intervention.
Results
Baseline Lp(a) concentrations were negatively associated with baseline ferritin (-0.12 μg/L [95%CI: -0.22, -0.02]) and body iron (-0.04 mg/kg [-0.8, -0.00]). Baseline Lp(a) concentrations were negatively associated with post-intervention transferrin saturation (-0.24% [-0.43, -0.06]) and serum iron (-0.82 μg/dL [-1.5, -0.2]) but positively associated with high sensitivity C-reactive protein (1.6% [0.3, 3.3]). No other associations were observed.
Conclusion
In women of reproductive age with low iron stores, higher baseline Lp(a) concentrations were associated with lower baseline iron stores (i.e., ferritin and body iron), as well as a blunted response in iron transport (transferrin saturation and serum iron) after an 8-week iron supplementation intervention. These findings suggest that elevated Lp(a) could influence the response to iron repletion, warranting confirmation in larger prospective studies. Registered at clinicaltrials.gov (NCT04793906).